Avoiding the Compensation Trap: Protecting Your Capital Gains in a Healthcare Buyout
For many physicians, dentists, and healthcare specialists, the culmination of a career is the sale of their private practice. In recent years, Private Equity (PE) firms have emerged as the dominant buyers in the healthcare sector, offering high valuation multiples and the promise of administrative relief. However, a high purchase price does not always equate to a high net-off. Without sophisticated tax planning, a significant portion of your hard-earned equity can be eroded by federal and state taxes.
As we move through 2026, the tax landscape has become increasingly complex following the implementation of the One Big Beautiful Bill Act (OBBBA). Successful exit planning now requires a multi-year strategy that addresses asset allocation, the rollover equity structure, and the timing of the closing. For a medical or dental practice owner, the goal is to shift as much of the gain as possible from high ordinary income rates to more favorable long-term capital gains rates.
The Importance of Purchase Price Allocation
One of the most critical battlegrounds in a PE transaction is the allocation of the purchase price under Section 1060. The IRS requires both the buyer and the seller to agree on the value of various asset classes, such as equipment, furniture, patient records, and goodwill. Because buyers and sellers have competing tax interests, this negotiation often dictates the final after-tax proceeds.
Buyers typically prefer to allocate more value to tangible assets like medical equipment to take advantage of 100% depreciation write-offs. Conversely, sellers want to maximize the allocation to Personal Goodwill. According to IRS guidance on asset acquisitions, goodwill is a Class VII asset that qualifies for long-term capital gains treatment, currently capped at 20% plus the 3.8% Net Investment Income Tax (NIIT).
Mastering the Rollover Equity Structure
Most PE firms do not buy 100% of a practice for cash. Instead, they require the founding physician to roll over 20% to 30% of their equity into the new entity. This rollover serves as a powerful incentive for the doctor to remain productive, but it also presents a unique tax opportunity. If structured correctly as a Section 721 contribution, this rollover can be treated as a tax-deferred exchange.
Under a Section 721 exchange, the portion of your practice that you contribute to the PE-backed partnership is not taxed at the time of the sale. Tax is only recognized when you eventually exit the new platform, often referred to as the second bite of the apple. As noted by Bloomberg Tax’s analysis of healthcare PE trends, failing to meet the control or continuity of interest requirements can lead to an accidental taxable event on the entire value of the practice, even the portion you didn’t receive in cash.
Navigating the 1202 Small Business Exclusion
For practitioners who structured their business as a C-Corporation from the outset, Section 1204 (the Qualified Small Business Stock (QSBS) exclusion) can be a total game-changer. If your practice meets the requirements, you may be able to exclude the greater of $10 million or 10 times your basis from federal capital gains tax entirely.
To qualify for this tax-free exit, the practice must be a domestic C-Corp, have less than $50 million in assets at the time the stock was issued, and the stock must have been held for at least five years. However, the OBBBA has introduced stricter active trade or business tests for healthcare entities. According to PwC’s summary of QSBS limitations, the IRS often scrutinizes medical practices to ensure the value is derived from the business rather than the reputation of a single individual. Early consultation with a tax strategist is required to ensure your entity structure qualifies before the Letter of Intent (LOI) is signed.
The Compensation Trap: Ordinary Income vs. Capital Gains
PE firms often require selling doctors to sign employment agreements with lower-than-market salaries, effectively shifting what would have been wages into the purchase price. While this increases the sale value (taxed at capital gains), the IRS may recharacterize a portion of the purchase price as deferred compensation (taxed at ordinary income rates) if the salary is deemed unreasonably low.
In 2026, the gap between the top ordinary rate (39.6% under OBBBA) and the capital gains rate (23.8% including NIIT) is nearly 16%. Ensuring that your post-sale compensation is fair market value is essential to protecting your capital gains treatment. A professional valuation of your clinical services can serve as a robust defense against an IRS challenge that the purchase price was actually a disguised salary.
State Tax Considerations and Residency Planning
While federal taxes are the primary concern, state taxes can take another 5% to 13% of your sale proceeds depending on your location. Successful individuals in high-tax states like California or New York often explore residency planning years before a sale.
Establishing a legal domicile in a no-income-tax state like Florida, Texas, or Nevada requires more than just a PO Box. You must demonstrate a change in your center of gravity, including where you spend time, where you vote, and where your primary professional licenses are held. For a medical practice owner, this often means selling the practice and the real estate simultaneously to cut all ties to the high-tax jurisdiction.
Charitable Lead Trusts (CLT) as a Pre-Sale Hedge
For the charitably inclined, a Charitable Lead Trust (CLT) can be a powerful tool to offset the massive income spike in the year of the sale. By contributing a portion of the practice interests to a CLT before the sale is finalized, you can generate a significant charitable deduction to offset the gain from the cash portion of the sale.
The CLT pays an annuity to your chosen charities for a set number of years, after which the remaining assets pass back to your heirs, often with little to no gift tax. When combined with FLP discounting strategies, the CLT can effectively wash out the tax liability of a PE exit while securing your family’s philanthropic legacy.
Securing Your Legacy with Expert Guidance
Selling to Private Equity is a once-in-a-career event. The complexity of Section 1060 allocations, Section 721 rollovers, and state nexus rules means that your standard CPA may not have the specialized experience required for a mid-market healthcare transaction. The 16% spread between ordinary income and capital gains, combined with the permanent 100% depreciation rules of the OBBBA, creates a high-stakes environment where a single structural error can cost millions.
Find Your Exit Strategy Expert Today
Tax-efficient exit planning is not a task for the final months of a deal, it is a multi-year process that should begin long before the first PE firm reaches out. To maximize your after-tax wealth and ensure your rollover equity is truly tax-deferred, you need a strategist who specializes in healthcare M&A and OBBBA compliance. The Top Tax Planners Directory connects practice owners with the nation’s most elite tax professionals, each vetted for their expertise in Private Equity transactions and high-net-worth wealth preservation. Don’t leave your career’s work to chance. Visit the Top Tax Planners Directory today to find a qualified tax professional who can help you engineer a tax-efficient exit and protect your financial future.